A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer
Year: 2019
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Cancer
DOI: 10.1002/cncr.32179
Authors: Vijay Maruti Patil, Vanita Noronha, Amit Joshi, Jaiprakash Agarwal, Sarbani Ghosh‐Laskar, Ashwini Budrukkar, Vedang Murthy, Tejpal Gupta, Manoj Mahimkar, Shashikant Juvekar, Supreeta Arya, Abhishek Mahajan, Archi Agarwal, Nilendu Purandare, Venkatesh Rangarajan, Arun Balaji, Sameer Vasant Chaudhari, Shripad Banavali, Sadhana Kannan, Atanu Bhattacharjee, Anil K. D’Cruz, Pankaj Chaturvedi, Prathamesh S. Pai, Devendra Chaukar, Gouri Pantvaidya, Deepa Nair, Sudhir Nair, Anuja Deshmukh, Shivakumar Thiagarajan, Vijayalakshmi Mathrudev, Aparna Manjrekar, Sachin Dhumal, Kamesh Maske, Arti Sanjay Bhelekar, Kavita Nawale, Arun Chandrasekharan, Nikhil Pande, Alok Goel, Vikas Talreja, Vijai Simha, Sujay Srinivas, Rohit Swami, Dilip Harindran Vallathol, Hollis Dsouza, Sameer Shrirangwar, Siddharth Turkar, George Abraham, Aditi Harsh Thanky, Usha Patel, Manish Kumar Pandey, Kumar Prabhash
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Biocon
Award: G5550982635
OpenAlex ID: W2947636764